KC Waterman, GS Goeken, S Konagurthu… - Journal of Controlled …, 2011 - Elsevier ... reducing theory to practice, in Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice, H. Wen, K. Park, Eds., Wiley: Hoboken, NJ, 2010, pp. 129-154. 19. V. Malaterre, J. Ogorka, N. Loggia, R.Gurny, Approach to design push-pull osmoticpumps, Int. ... All 2 versions
[HTML] from lipidworld.comR Kumaravelrajan, N Narayanan… - Lipids in health and …, 2011 - lipidworld.com ... Verma RK, Garg S: Development and evaluation of osmotically controlled oral drug delivery system of glipizide. ... Jensen JL, Appel LE, Clair JH, Zentner GM: Variables that affect the mechanism of drug release from osmoticpumps coated with acrylate/methacrylate copolymer ... Related articles - Cached - All 6 versions
J Andersson… - European Journal of Oral Sciences, 2011 - Wiley Online Library ... into contact with cells of the immune system that are present in the oral mucosa and in the dental pulp. In this study, our aim was to develop a model of long-term exposure to minute amounts of HEMA and to record the immunological effects in mice. Osmoticpumps filled with ... Cited by 2 - Related articles - All 3 versions
A Chaudhary, N Tiwari, V Jain… - European Journal of …, 2011 - Elsevier ... 2.2.6. Release models and kinetics Generally the release of drug from oralosmotic systems is controlled by various factors such ... of release retardants especially hydrophilic polymers (HPMC+NaCMC) can control the release of highly water soluble drug from the osmoticpumps. ... All 2 versions
[PDF] from gu.seJ Andersson - 2011 - gupea.ub.gu.se ... 12 Characteristics and Function in Dental Resin Materials 12 HEMA Leakage and Leukocytes in the Oral Cavity 13 Innate Immunity: Neutrophils and Monocytes ... Effects of HEMA Exposure in vivo (III, IV) 28 Animal Husbandry 28 HEMA Exposure in vivo - OsmoticPumps (III) 28 ... Related articles